Cited by 807Cardiomyopathy and Myosin StudiesCardiovascular Effects of ExerciseViral Infections and Immunology Research

The DOI matches its Crossref record; 518 of the 518 references it cites were found in a registry or an index.

2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines

Ommen, Steve R., Ho, Carolyn Y., Asif, Irfan M., Balaji, Seshadri, Burke, Michael A., Day, Sharlene M., Dearani, Joseph A., Epps, Kelly C., Evanovich, Lauren, Ferrari, Victor A., Joglar, José A., Khan, Sadiya S., Kim, Jeffrey J., Kittleson, Michelle M., Krittanawong, Chayakrit, Martinez, Matthew W., Mital, Seema, Naidu, Srihari S., Saberi, Sara, Semsarian, Christopher, Times, Sabrina, Waldman, Cynthia Burstein·2024·Circulation

DOI 10.1161/cir.0000000000001250

Open this paper in CoChat — free account

Abstract

AIM: The “2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy” provides recommendations to guide clinicians in the management of patients with hypertrophic cardiomyopathy. METHODS: A comprehensive literature search was conducted from September 14, 2022, to November 22, 2022, encompassing studies, reviews, and other evidence on human subjects that were published in English from PubMed, EMBASE, the Cochrane Library, the Agency for Healthcare Research and Quality, and other selected databases relevant to this guideline. Additional relevant studies, published through May 23, 2023, during the guideline writing process, were also considered by the writing committee and added to the evidence tables, where appropriate. STRUCTURE: Hypertrophic cardiomyopathy remains a common genetic heart disease reported in populations globally. Recommendations from the “2020 AHA/ACC Guideline for the Diagnosis and Treatment of Patients With Hypertrophic Cardiomyopathy” have been updated with new evidence to guide clinicians.

Integrity signals

Registry

Crossref · 10.1161/cir.0000000000001250

Cites

518 of 518 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
Hindricks, G., Potpara, T., Dagres, N., Arbelo, E., Bax, J. J., Blomström‐Lundqvist, C., Boriani, G., Castella, M., Dan, G.-A., Dilaveris, P., et al. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa612 · Cited by 10,550
The Physical Activity Guidelines for Americans
Piercy, K. L., Troiano, R. P., Ballard, R. M., Carlson, S. A., Fulton, J. E., Galuska, D. A., George, S. M., & Olson, R. D. (2018) · JAMA · doi:10.1001/jama.2018.14854 · Cited by 9,755
2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
January, C. T., Wann, L. S., Alpert, J. S., Calkins, H. G., Cigarroa, J. E., Cleveland, J. C., CONTI, J. B., Ellinor, P. T., Ezekowitz, M. D., Field, M. E., et al. (2014) · Circulation · doi:10.1161/cir.0000000000000041 · Cited by 7,145
2011 Compendium of Physical Activities: A Second Update of Codes and MET Values
AINSWORTH, B. E., HASKELL, W. L., HERRMANN, S. D., MECKES, N., BASSETT, D. R., TUDOR-LOCKE, C., GREER, J. L., VEZINA, J., WHITT-GLOVER, M. C., & LEON, A. S. (2011) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31821ece12 · Cited by 6,317
The Effect of Cardiac Resynchronization on Morbidity and Mortality in Heart Failure
Cleland, J. G. F., Daubert, J., Erdmann, E., Freemantle, N., Gras, D., KAPPENBERGER, L. J., & Tavazzi, L. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa050496 · Cited by 6,300
2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Heidenreich, P. A., Bozkurt, B., Aguilar, D., Allen, L. A., Byun, J. J., Colvin, M. M., Deswal, A., Drazner, M. H., Dunlay, S. M., Evers, L. R., et al. (2022) · Circulation · doi:10.1161/cir.0000000000001063 · Cited by 4,922
Self-citation
2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines.
Arnett, D. K., Blumenthal, R. S., Albert, M. A., Buroker, A. B., Goldberger, Z. D., Hahn, E. J., Himmelfarb, C. D., Khera, A., Lloyd-Jones, D., McEvoy, J. W., et al. (2019) · Circulation · doi:10.1161/cir.0000000000000678 · Cited by 4,536
2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy
Authors/Task Force members, Elliott, P. M., Anastasakis, A., Borger, M. A., Borggrefe, M., Cecchi, F., Charron, P., Hagege, A. A., Lafont, A., Limongelli, G., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu284 · Cited by 4,332
2020 ACC/AHA Guideline for the Management of Patients With Valvular Heart Disease: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines
Otto, C. M., Nishimura, R. A., Bonow, R. O., Carabello, B. A., Erwin, J. P., Gentile, F., Jneid, H., Krieger, E. V., Mack, M., McLeod, C., et al. (2021) · Circulation · doi:10.1161/cir.0000000000000923 · Cited by 3,686

Show all 514 references

Research works printed but not linked: 227

Committee on Standards for Systematic Reviews of Comparative Effectiveness Research Institute of Medicine (US). Finding What Works in Health Care: Standards for Systematic Reviews. National Academies Press; 2011.
Animal Studies-Standard-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022. Accessed September 14, 2022. https://searchfilters.cadth.ca/link/54.
Guidelines-Broad-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022. Accessed September 14, 2022. https://searchfilters.cadth.ca/link/75.
Guidelines-Standard-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022. Accessed September 14, 2022. https://searchfilters.cadth.ca/link/77.
RCT/ CCT-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022. Accessed September 14, 2022. https://searchfilters.cadth.ca/link/108.
SR/ MA/ HTA/ ITC-PubMed. In: CADTH Search Filters Database. Ottawa: CADTH; 2022: Accessed September 14, 2022. https://searchfilters.cadth.ca/link/99.
10.1016/s0025-6196(11)64198-0 · DOI
10.1016/j.jacc.2014.05.003 · DOI · Paper page
10.1056/nejmra1710575 · DOI · Paper page
10.1161/circulationaha.117.033200 · DOI · Paper page
10.1001/jamacardio.2015.0354 · DOI · Paper page
10.1056/nejmra1710575 · DOI · Paper page
10.1016/j.jacc.2015.01.019 · DOI
10.1016/j.jacc.2014.05.003 · DOI · Paper page
10.1016/j.jacc.2018.10.007 · DOI
10.1016/j.echo.2010.10.006 · DOI
10.1161/circulationaha.106.644682 · DOI
10.1016/j.amjcard.2017.08.047 · DOI
10.1093/ehjci/jew313 · DOI
10.1016/j.jacc.2005.02.090 · DOI
10.1093/eurheartj/ehz396 · DOI
10.1016/j.jacc.2013.02.079 · DOI
10.1016/j.jacc.2016.11.063 · DOI
10.1161/circulationaha.105.583500 · DOI
10.1016/j.jacc.2016.01.071 · DOI
10.1016/j.jacc.2012.03.076 · DOI
10.1016/j.jacc.2010.11.002 · DOI
10.1016/j.echo.2011.03.006 · DOI
10.1161/circulationaha.107.698985 · DOI
10.1016/j.jcin.2011.02.014 · DOI
10.1016/j.amjcard.2007.09.111 · DOI
10.1161/01.cir.0000097110.55312.bf · DOI
10.1016/j.echo.2010.10.006 · DOI
10.1161/circulationaha.106.644682 · DOI
10.1016/j.amjcard.2017.08.047 · DOI
10.1093/ejechocard/jeq063 · DOI
10.1093/ehjci/jew313 · DOI
10.1136/hrt.2007.126003 · DOI
10.1056/nejmoa021332 · DOI · Paper page
10.1016/s0002-9149(99)80416-0 · DOI
10.1161/01.cir.0000162460.36735.71 · DOI
10.1016/j.jacc.2013.02.079 · DOI
10.1161/hcg.0000000000000054 · DOI
10.1093/eurheartj/ehq271 · DOI
10.1016/j.jacc.2012.02.068 · DOI
10.1161/circgen.117.001896 · DOI · Paper page
10.1161/circulationaha.114.013478 · DOI
10.1093/eurheartj/ehz396 · DOI
10.1161/circulationaha.117.033200 · DOI · Paper page
10.1016/j.hrthm.2011.07.017 · DOI
10.1161/circulationaha.111.090514 · DOI
10.1161/circgenetics.116.001620 · DOI
10.1161/circulationaha.118.038846 · DOI
10.1016/j.jacc.2015.01.019 · DOI
10.1161/circulationaha.111.090514 · DOI
10.1093/eurheartj/ehz396 · DOI
10.1161/circulationaha.118.037264 · DOI
10.1161/circulationaha.118.038846 · DOI
10.1016/j.jpeds.2017.03.033 · DOI
10.1093/eurheartj/ehr092 · DOI · Paper page
10.1148/radiol.2018180339 · DOI
10.1161/circulationaha.105.583500 · DOI
10.1016/j.jacc.2016.11.063 · DOI
10.1016/s0735-1097(03)00827-1 · DOI · Paper page
10.1161/circep.116.004604 · DOI
10.1007/s10554-016-0858-4 · DOI
10.1016/j.amjcard.2016.11.010 · DOI
10.1016/j.amjcard.2010.01.367 · DOI
10.1016/j.jcmg.2016.02.031 · DOI
10.1161/circulationaha.113.007094 · DOI · Paper page
10.1016/j.jacc.2018.05.060 · DOI
10.1136/heartjnl-2013-305471 · DOI
10.1016/j.echo.2011.03.002 · DOI
10.1016/j.jacc.2015.02.061 · DOI · Paper page
10.1161/circulationaha.120.047235 · DOI
10.1111/cge.13157 · DOI
10.1016/j.hrthm.2019.04.040 · DOI
10.1093/europace/euz118 · DOI
10.1161/circulationaha.122.062699 · DOI
10.1161/circulationaha.120.047235 · DOI
10.1001/jamacardio.2019.2861 · DOI
10.1001/jamacardio.2018.0789 · DOI
10.1016/j.hrthm.2019.04.040 · DOI
10.1093/europace/euz118 · DOI
10.1177/2047487317702519 · DOI
10.1161/circheartfailure.113.000414 · DOI
10.1016/j.amjcard.2013.12.034 · DOI
10.1111/chd.12286 · DOI
10.1093/eurjpc/zwab181 · DOI
10.1016/j.jacc.2015.03.552 · DOI
10.1111/cge.13157 · DOI
10.1016/j.jacc.2016.11.063 · DOI
10.1016/j.jjcc.2014.02.011 · DOI
10.1007/s10554-016-0858-4 · DOI
10.1016/j.amjcard.2016.11.010 · DOI
10.1016/j.amjcard.2010.01.367 · DOI
10.1016/j.jcmg.2016.02.031 · DOI
10.1161/circulationaha.113.007094 · DOI · Paper page
10.1016/j.jacc.2018.05.060 · DOI
10.1001/jamacardio.2019.1391 · DOI
10.1161/circulationaha.105.583500 · DOI
10.1136/heartjnl-2013-305471 · DOI
10.1016/j.jacc.2020.04.045 · DOI
10.1161/circulationaha.119.044366 · DOI · Paper page
10.1016/j.jacc.2015.02.061 · DOI · Paper page
10.1161/circulationaha.122.062699 · DOI
10.1016/s0735-1097(99)00056-x · DOI
10.1016/j.amjcard.2010.06.077 · DOI · Paper page
10.1056/nejm200006153422403 · DOI
10.1016/s0140-6736(00)04005-8 · DOI
10.1161/circulationaha.108.798314 · DOI · Paper page
10.1016/s0735-1097(03)00827-1 · DOI · Paper page
10.1161/circep.116.004604 · DOI
10.1017/s1047951105001824 · DOI
10.1038/nrcardio.2017.6 · DOI
10.1001/jamacardio.2019.1391 · DOI
10.1001/jama.298.4.405 · DOI
10.1016/j.ahj.2013.06.009 · DOI
10.1016/s0735-1097(99)00056-x · DOI
10.1161/circulationaha.108.798314 · DOI · Paper page
10.1016/j.amjcard.2010.06.077 · DOI · Paper page
10.1093/eurheartj/ehq308 · DOI
10.1056/nejm200006153422403 · DOI
10.1016/j.jacc.2004.12.067 · DOI
10.1016/s0140-6736(00)04005-8 · DOI
10.1161/circulationaha.105.583500 · DOI
10.1016/j.jacc.2016.11.063 · DOI
10.1016/j.jjcc.2014.02.011 · DOI
10.1016/s0735-1097(03)00827-1 · DOI · Paper page
10.1161/circep.116.004604 · DOI
10.1136/heartjnl-2013-305471 · DOI
10.1093/eurheartj/eht439 · DOI · Paper page
10.1016/j.jacc.2020.04.045 · DOI
10.1161/circulationaha.119.044366 · DOI · Paper page
10.1016/j.jacc.2013.01.037 · DOI
10.1177/2047487317702519 · DOI
10.1007/s00246-011-9967-y · DOI
10.1016/s0735-1097(98)00493-8 · DOI
10.1016/j.jacc.2015.03.552 · DOI
10.1007/s00246-013-0676-6 · DOI
10.1161/circulationaha.115.017633 · DOI
10.1161/circulationaha.120.047235 · DOI
10.1093/eurjpc/zwab181 · DOI
10.1161/circulationaha.113.007094 · DOI · Paper page
10.1016/j.jcmg.2016.02.031 · DOI
10.1016/j.jacc.2018.05.060 · DOI
10.1016/j.amjcard.2013.12.034 · DOI
10.1161/circulationaha.112.136085 · DOI · Paper page
10.1016/j.jacc.2015.02.061 · DOI · Paper page
10.1016/j.amjcard.2020.04.042 · DOI
10.1016/j.hrthm.2019.04.040 · DOI
10.1016/j.jacc.2009.03.051 · DOI
10.1016/j.jacc.2013.01.037 · DOI
10.1161/cir.0000000000001063 · DOI · Paper page
10.1161/cir.0000000000000628 · DOI · Paper page
10.1161/circulationaha.106.644682 · DOI
10.1016/j.jacc.2005.02.090 · DOI
10.1016/j.jacc.2015.06.1333 · DOI · Paper page
10.1161/circulationaha.106.644682 · DOI
10.1016/j.jacc.2005.02.090 · DOI
10.1016/j.amjcard.2013.01.340 · DOI
10.1016/j.jcmg.2013.08.010 · DOI
10.1001/jamacardio.2016.0252 · DOI
10.1016/j.jtcvs.2018.11.148 · DOI
10.1016/j.mayocp.2018.07.022 · DOI
10.1016/j.jacc.2016.07.735 · DOI · Paper page
10.1016/j.echo.2018.10.011 · DOI
10.1136/hrt.2007.118018 · DOI
10.1161/circulationaha.117.029267 · DOI · Paper page
10.1161/01.cir.0000162460.36735.71 · DOI
Liebregts, M, Vriesendorp, PA, Mahmoodi, BK, et al. A systematic review and meta-analysis of long-term outcomes after septal reduction therapy in patients with hypertrophic cardiomyopathy. J Am Coll Cardiol HF. 2015;3:896–905.
10.1536/ihj.27.701 · DOI
10.1161/circulationaha.117.033200 · DOI · Paper page
10.1161/01.cir.0000097110.55312.bf · DOI
10.1161/cir.0000000000001063 · DOI · Paper page
10.1161/circulationaha.105.583500 · DOI
10.1093/eurheartj/ehq136 · DOI
10.1161/circheartfailure.114.002248 · DOI · Paper page
10.1253/circj.cj-16-0432 · DOI
10.1016/j.amjcard.2017.12.044 · DOI
10.1016/s0140-6736(20)31792-x · DOI · Paper page
10.1016/j.jacc.2020.04.045 · DOI
10.1016/j.ejheart.2008.03.006 · DOI
Gu, M, Jin, H, Hua, W, et al. Clinical outcome of cardiac resynchronization therapy in dilated-phase hypertrophic cardiomyopathy. J Geriatr Cardiol. 2017;14:238–244.
10.1016/j.jacc.2017.11.040 · DOI
10.1093/europace/euw327 · DOI
Rowin, EJ, Mohanty, S, Madias, C, et al. Benefit of cardiac resynchronization therapy in end-stage nonobstructive hypertrophic cardiomyopathy. J Am Coll Cardiol EP. 2019;5:131–133.
10.1136/heartjnl-2013-305471 · DOI
10.1161/circulationaha.119.044366 · DOI · Paper page
10.1161/circheartfailure.114.001843 · DOI · Paper page
10.1016/s2213-8587(14)70241-4 · DOI
10.1016/j.amjcard.2016.08.092 · DOI
10.1111/jce.12982 · DOI
10.1161/circulationaha.117.029267 · DOI · Paper page
10.1016/j.jacc.2005.01.012 · DOI · Paper page
10.1161/jaha.116.005152 · DOI
10.1016/j.amjcard.2003.10.025 · DOI
10.1016/j.amjcard.2017.12.044 · DOI
10.1161/circheartfailure.114.001435 · DOI
10.1161/circep.110.957290 · DOI

200 of 227 shown

Sorted by citations

Items 701–800 of 806

Results of a long-term follow-up of patients with hypertrophic cardiomyopathy after pregnancy
Nikolaeva, A. A., Karelkina, E. V., Zaĭtsev, V. V., Svistelnikova, E. V., Konasov, K. S., Irtyuga, O. B., & Моисеева, О. М. (2026) · Russian Journal of Cardiology · doi:10.15829/1560-4071-2026-6957
Hypertrophic Cardiomyopathy in the Era of Precision Medicine: Redefining Diagnosis, Therapeutics and Risk
Saldarriaga, C. (2026) · Cardiac failure review · doi:10.15420/cfr.2026.19
A multidisciplinary preoperative triage and optimization tool for hypertrophic cardiomyopathy: Advancing resource utilization and patient safety
Ikpot, I. Z., Tolman, A. D., Besharat, S., & Lander, H. L. (2026) · Journal of Clinical Anesthesia · doi:10.1016/j.jclinane.2026.112302
Association of Cardiovascular Magnetic Resonance-Derived Papillary Muscle Abnormalities with Non-Sustained Ventricular Tachycardia in Hypertrophic Cardiomyopathy
Güven, B., Deni̇z, M. F., Özkan, F., Geylan, N. A., Si̇nan, Ü. Y., Can, T. S., & Oktay, V. (2026) · Diagnostics · doi:10.3390/diagnostics16162599
Development and validation of an HPLC-MS/MS method for the quantification of Aficamten in human plasma and urine and application to a clinical pharmacokinetic study
Wu, X., Liu, A., Griffith, A., Liu, H., Zhao, X., Wang, H., & Han, X. (2026) · Journal of Chromatography B · doi:10.1016/j.jchromb.2026.125259
Forward Dynamics: Modern Insights into Mitral Systolic Anterior Motion
Bouhaik, F. S., Monaco, I., Sedrati, M., Bouvet, A., Gervais, B., Trivelloni, V., Bencharef, Y., Sekkal, F. M., & Bottigliero, D. (2026) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd13080397
Left Atrial Strain: A Sentinel of Ventricular Arrhythmic Risk in Hypertrophic Cardiomyopathy
Peters, M. G., & Phelan, D. (2026) · Journal of the American Society of Echocardiography · doi:10.1016/j.echo.2026.08.017
Artificial Intelligence to Unmask LVOT Obstruction in Hypertrophic Cardiomyopathy
Massera, D., & Sherrid, M. V. (2026) · Circulation Cardiovascular Imaging · doi:10.1161/circimaging.126.020318
Initial Clinical Experience with Percutaneous Endocardial Septal Pulsed Field Ablation in Hypertrophic Obstructive Cardiomyopathy: A First-in-Human Case Series
Zhang, H., Tian, Y., Yang, S., Cao, R., Jing, H., Gong, C., Zhong, J., Chen, Y., Hong, S., & Wang, Z. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15176620
Artificial intelligence-empowered echocardiography: an updated review of clinical management in hypertrophic cardiomyopathy
Zhang, M., Yuan, S., Dai, H., & Wang, G. (2026) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2026.1787664
Defining Meaningful Treatment Responses in Hypertrophic Cardiomyopathy: Seeking a Trifecta Across Phenotypes
Wang, A. (2026) · Circulation · doi:10.1161/circulationaha.126.082802
Finding Time to Relax: The Diastolic Signature of Aficamten in Nonobstructive Hypertrophic Cardiomyopathy
Reza, N. (2026) · Circulation · doi:10.1161/circulationaha.126.082804
First we feast: a narrative review of postprandial assessment of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy
Chandrasekhar, M. A., Park, C., Burgess, P., & Stacey, R. B. (2026) · Echo Research and Practice · doi:10.1186/s44156-026-00135-1
How to Do Echo in Left Ventricular Hypertrophy: A Consensus Statement of the Italian Society of Echocardiography and Cardiovascular Imaging
Luca, A. D., Folgheraiter, A., Caiffa, T., Porcari, A., Cameli, M., Agricola, E., Piccione, M. C., Manganaro, R., Barison, A., Todiere, G., et al. (2026) · Journal of Cardiovascular Echography · doi:10.4103/jcecho.jcecho_119_26
Incremental prognostic value of late gadolinium enhancement in hypertrophic cardiomyopathy in a large contemporary cohort
Keen, S., Shah, S., Sheashaa, H., Abusafia, M., Jadam, S., Kaur, S., Gaballa, A., Ospina, S., Rutkowski, K., Ramchand, J., et al. (2026) · Cardiovascular Research · doi:10.1093/cvr/cvag181
Investigation of plasma-derived extracellular vesicles in hypertrophic cardiomyopathy patients
Rizzuto, A. S., Faggiano, A., Macchi, C., Fichtner, I., Bianchi, D., Mallia, A., Gnan, E., Tafuri, F., Pandolfi, A., Baroni, M., et al. (2026) · iScience · doi:10.1016/j.isci.2026.117301
Prospective evaluation of real-world safety, symptoms improvement and adherence to mavacamten among Iranian patients with hypertrophic obstructive cardiomyopathy (PERSIA-HOCM): protocol of a multicentre observational study
Raeini, A. G., Karimi, M. A., Shirinezhad, A., Aslani, M., Soheili, A., Ghaderi, A., Haghjoo, M., Bakhshandeh, H., & Naderi, N. (2026) · BMJ Open · doi:10.1136/bmjopen-2026-124273
Clinical Considerations for the Care of the Tactical Athlete With Cardiovascular Abnormalities: A Scientific Statement From the American College of Cardiology and the American Heart Association
Dineen, E. H., Haigney, M. C., Levine, B. D., Ackerman, M. J., Baggish, A. L., Batts, T. C., Braverman, A. C., Chung, E. H., Cole, G. J., Cornwell, W. K., et al. (2026) · Circulation · doi:10.1161/cir.0000000000001476
Self-citation
Reconstructing synthetic hearts from ECG using flow matchingPreprint
Zheng, J., Kalaie, S., Ma, Q., Meng, Q., Rjoob, K. W. Y., Gifani, P., Hu, L., Babazade, N., Corianò, M., Zhong, W., et al. (2026) · medRxiv · doi:10.64898/2026.09.01.26360987
Cardiovascular magnetic resonance for therapy monitoring in cardiomyopathies
Garofalo, M., Panichella, G., Clemente, A., Gori, C. D., Barison, A., Chianca, M., Aimo, A., & Todiere, G. (2026) · European Heart Journal - Imaging Methods and Practice · doi:10.1093/ehjimp/qyag153
Reconciling evidence-based and personalized medicine: perspectives in heart failure and cardiomyopathies
Finocchiaro, G., Perotto, M., Merlo, M., Lüscher, T. F., McKenna, W. J., & Sinagra, G. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag596
Impact of hypertrophic pattern and obstruction on cardiovascular magnetic resonance myocardial strain and left atrioventricular coupling in hypertrophic cardiomyopathy: a retrospective study
Li, Y., Li, Z., Chen, S., & Long, L. (2026) · Open Heart · doi:10.1136/openhrt-2026-004215
Cardiomyocyte hypertrophy co-localizes with accumulation of hyaluronan in cMyBPC+/- mice hearts
Strnadová, A., Ericsson, M., Nyrén, R., Dudka, I., Mörner, S., & Hellman, U. (2026) · PLoS ONE · doi:10.1371/journal.pone.0342635
A case of asymptomatic hypertrophic cardiomyopathy in outpatient practice
Голосова, А. Н., Владимирович, Г. С., Shupenina, E. Y., Ulyanova, E. A., Sitnik, S. I., & Proklova, O. I. (2026) · Russian Journal of Preventive Medicine · doi:10.17116/profmed20262908186
Стратификация риска внезапной сердечной смерти и терапия желудочковых аритмий у пациентов с кардиомиопатиями: лекция
Снежицкий, В. А. (2026) · Кардиология в Беларуси · doi:10.34883/pi.2026.18.4.006
Transcatheter Edge-to-Edge Repair for Mitral Valve Systolic Anterior Motion in Complex Left Ventricular Outflow Tract Phenotypes: A Case Series
Zorman, M., Gowda, S. N., Padang, R., Thaden, J. J., Guerrero, M. E., & Eleid, M. F. (2026) · Journal of the Society for Cardiovascular Angiography & Interventions · doi:10.1016/j.jscai.2026.105622
PARADOXO APICAL: RISCO ARRITMOGÊNICO SINÉRGICO NA SOBREPOSIÇÃO DA SÍNDROME DE YAMAGUCHI E DA CARDIOMIOPATIA CHAGÁSICA
Rosa, J. D., Rueda, P., Ferronatto, L. L., da Cunha, M. L. Q. A., & Luz, P. E. C. (2026) · Revista Contemporânea · doi:10.56083/rcv6n8-094
Early Inpatient Implementation of an ERAS-Informed Stepwise Rehabilitation Pathway After Percutaneous Intramyocardial Septal Radiofrequency Ablation for Obstructive Hypertrophic Cardiomyopathy: A Retrospective Cohort Study
Danyan, Y. A. N. G., Tan, B., Li, R., Zhu, Q., Li, H., & Mao, Y. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15187029
Left Atrium Myocardial Remodeling and Prognostic Marker Derived from CMR Feature Tracking in Pediatric Hypertrophic Cardiomyopathy
Chen, X. Y., Tang, Y., Ma, X., Yang, S., Yang, K., Wang, J., Dong, Z., Zhao, K., Wei, Z., Jia, X., et al. (2026) · Journal of Cardiovascular Magnetic Resonance · doi:10.1016/j.jocmr.2026.102798
Antitachycardia Pacing for Fast Scar-Mediated Ventricular Tachycardia Across Non-Ischemic Cardiomyopathies: A Case Series
Karakasis, P., Stavropoulos, G., Efthimiadis, G. K., Karamitsos, T., & Fragakis, N. (2026) · International Medical Case Reports Journal · doi:10.2147/imcrj.s629503
Medical Problems of the Athlete
Meredith, T. J., Antonawich, R., Molina, M. L., & Falk, N. P. (2026) · Springer eBooks · doi:10.1007/978-1-4939-0779-3_58-3
Hypertrophic cardiomyopathy: state of the art on diagnosis and current therapeutic approach
Franca, E. L., Parisi, F., Lucchino, A., Sade, L. E., Wong, T. C., Loddo, I., Alioto, L., Gentile, G., Pilato, M., Cipriani, M., et al. (2026) · Cardiovascular Ultrasound · doi:10.1186/s12947-026-00382-6
Athletes with Implantable Cardioverter-Defibrillators: A Practical Framework for Device Selection, Programming, and Return-to-Sport Risk Mitigation
Dimitri, D. S., & Prutkin, J. M. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15187103
Natural Missplicing Events Amplified by an Elusive Deep-Intronic MYBPC3 Variant Cause Hypertrophic Cardiomyopathy
Gallego‐Delgado, M., Hernández, S. M. L., García-Hernández, S., Diego, S. R., Jung, D. H. H., Pampín, E. M., Pérez‐Barbeito, M., Monsalvo, M. G., Berrocal, B. G., Rincon, L. M., et al. (2026) · Circulation · doi:10.1161/circulationaha.125.078812
Left Atrial Strain as an Integrative Marker of Diastolic Dysfunction and Atrial Fibrillation in Hypertrophic Cardiomyopathy: A Retrospective Cross-Sectional Study
Tamulėnaitė, E., Ažukaitė, J., Šukys, M., & Ereminienė, E. (2026) · Medicina · doi:10.3390/medicina62091787
Left Atrial Volume Index, Left Ventricular Outflow Tract Gradient, and Incident Atrial Fibrillation in Hypertrophic Cardiomyopathy
Salman, O., Pradeep, A. G., Purkayastha, S., Parikh, V., & Stahl, E. P. (2026) · Echocardiography · doi:10.1111/echo.70624
Anesthesia management for cochlear implantation in a child with Noonan syndrome complicated by hypertrophic cardiomyopathy: A case report
Zhao, X., Jiao, F., Li, G., & Wang, Y. (2026) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2026.07.090
The molecular landscape of hypertrophic cardiomyopathy across disease stages and genotypes
Adami, E., Kim, Y., Zheng, S. L., Shvetsov, N., Losert, C., Maatz, H., Barish, S., Venturini, G., López-Anguita, N., Shi, Q., et al. (2026) · Science Translational Medicine · doi:10.1126/scitranslmed.aea2747
Self-citation
A parsimonious machine learning model for predicting postoperative hypoxemia after septal myectomy in hypertrophic obstructive cardiomyopathy
Li, J., Xiao, X., Zhang, J., & Yin, Z. (2026) · Asian Journal of Surgery · doi:10.1016/j.asjsur.2026.08.094
The second beat matters: coupling intervals and sudden cardiac death risk in hypertrophic cardiomyopathy
Dinesen, R. B., Probst, V., & Tfelt‐Hansen, J. (2026) · EP Europace · doi:10.1093/europace/euag246
Tailoring Pediatric Cardiac Rehabilitation to the Underlying Cardiac Disease
Ward, K. M., McMahon, M., Vogel, C., Shekaran, M., Gambetta, K., McNulty, D. C., Peters, K., Allen, K. Y., & Hauck, A. L. (2026) · Current Treatment Options in Pediatrics · doi:10.1007/s40746-026-00388-2
When genetics meets destiny: rethinking hypertrophic cardiomyopathy through the lens of genotype
Maurizi, N., & Pieroni, M. (2026) · The Journal of Cardiovascular Aging · doi:10.20517/jca.2026.72
Beta-Blockers for the Treatment of Arrhythmias: Which Drug for Which Arrhythmia? A State-of-the-Art Narrative Review
Mureşan, L., Cismaru, G., Popa, S., Roşu, R., Guşetu, G., Puiu, M., Mada, R. O., Muresan, C., Bouar, R. L., Schiau, S., et al. (2026) · American Journal of Cardiovascular Drugs · doi:10.1007/s40256-026-00828-2
A novel MYH7 p.Thr265Ile mutation induces hypertrophic cardiomyopathy via mitochondrial energy crisis
Hao, Y., Zhang, X., Zhang, L., Zhang, Y., Wang, X., Cheng, Y., Wang, J., Ye, H., Duan, S., Liu, H., et al. (2026) · Acta Biochimica et Biophysica Sinica · doi:10.3724/abbs.2026177
Multimodality assessment for sudden cardiac death risk stratification in non-ischemic cardiomyopathy: A case-based framework integrating cardiac magnetic resonance, electrophysiologic observations, and genetics
Litt, M. J., Oraii, A., Garcia, F. C., Nazarian, S., Frankel, D. S., Deo, R., & Marchlinski, F. E. (2026) · Indian Pacing and Electrophysiology Journal · doi:10.1016/j.ipej.2026.09.010
General Aspects of Cardiac Magnetic Resonance in Cardiomyopathies
Luca, A. D., Belgrano, M., Vitrella, G., Altinier, A., Bernabei, A., Valenti, M., Pagnan, L., & Sarno, A. (2026) · Springer eBooks · doi:10.1007/978-3-032-34334-5_2
Sport and Exercise (Including CPET Evaluation)
Carriere, C., Baracchini, N., Capovilla, T., Savonitto, G., Tavčar, I., Paldino, A., Luca, A. D., Merlo, M., & Sinagra, G. (2026) · Springer eBooks · doi:10.1007/978-3-032-34334-5_11
Hypertrophic obstructive cardiomyopathy with associated pulmonary arteriopathy: A histopathologic perspective from sudden cardiac death
Gangwal, P., Kumar, P. S. S., Meshram, V., Jaggi, R. S., & Khera, S. (2026) · Journal of Forensic and Legal Medicine · doi:10.1016/j.jflm.2026.103266
Mechanical circulatory support in hypertrophic cardiomyopathy with cardiogenic shock: A National Inpatient Sample analysis
Sivakumar, N., Puchongmart, C., Padovese, C., Sodsri, T., Thiravetyan, B., Soliman, D., Srikulmontri, T., & Maharaj, V. (2026) · Cardiovascular revascularization medicine · doi:10.1016/j.carrev.2026.09.010
U-shaped catheter strategy for percutaneous endocardial septal radiofrequency ablation in hypertrophic obstructive cardiomyopathy: A retrospective comparative study
Liu, P., Huang, F., Zhu, W., Gao, G., Fan, B., & Wang, H. (2026) · Heart Rhythm · doi:10.1016/j.hrthm.2026.09.043
Echocardiography as the Rosetta Stone in Cardiomyopathies: A Step Closer
Prasad, S. B., Lo, A. X., & Atherton, J. J. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.126.053673
Complication management in hypertrophic cardiomyopathy
Höller, V., Zwetsloot, P.-P. M., Santner, V., Schwegel, N., Pötsch, S. L., Verheyen, N., & Michels, M. (2026) · Heart Failure Reviews · doi:10.1007/s10741-026-10682-8
Pathogenesis, screening, and diagnosis of hypertrophic cardiomyopathy
Gilreath, K. M., Newman, D. B., Ommen, S. R., & Geske, J. B. (2026) · BMJ Medicine · doi:10.1136/bmjmed-2025-002433
Self-citation
Atrial substrate and electrogram characterization in patients with atrial fibrillation and hypertrophic cardiomyopathy
Mascia, G., Olivotto, I., Barca, L., Zucchelli, G., Ramos‐Maqueda, J., Bianco, D., Parollo, M., Millesimo, M., Sartori, P., Melero‐Polo, J., et al. (2026) · Heart Rhythm O2 · doi:10.1016/j.hroo.2026.09.017
Cardiac deceleration capacity refines sudden cardiac death risk stratification in patients with hypertrophic cardiomyopathy for primary prevention
Lai, Z., Li, X., Fan, S., Hou, Z., Zhu, H., He, C., Yao, Y., & Fan, X. (2026) · The American Journal of Medicine · doi:10.1016/j.amjmed.2026.09.032
Echocardiographic Wall Thickness Heterogeneity as Marker of Hypertrophic Cardiomyopathy: A Proof-of-Concept Analysis From the Prospective Multicenter IMAGE-HCM StudyPreprint
Barki, M., Biondi, F., Aresu, A., Colombi, R., Cunsolo, P., Fanti, D., Zaccuri, M., Escalar, G., Fabris, M., Margonato, D., et al. (2026) · Research Square · doi:10.21203/rs.3.rs-11087470/v1
Implantable Cardioverter Defibrillators in Hypertrophic Cardiomyopathy: Global Insights From Worldwide Registries
Mason, P. K., & Kramer, C. M. (2026) · Circulation · doi:10.1161/circulationaha.126.079687
Apical Hypertrophic Cardiomyopathy masquerading as non-ST segment Elevation Acute Coronary Syndrome (NSTE-ACS) in a middle-aged woman
Ojo, E. O. (2025) · Nigerian Stethoscope
New-Onset Atrial Fibrillation After Alcohol Septal Ablation Versus Surgical Myectomy in Obstructive Hypertrophic Cardiomyopathy: A Propensity-Matched Analysis
Elgozair, M., Abdelazeem, B., Haddad, A. W., Abouzeid, W., Lataifeh, H., Asad, A., Elchouemi, M., & Stien, R. (2026) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2026.09.032
Ecocardiografia POCUS nella Cardiologia Pediatrica territoriale: esperienza pilota e impatto organizzativo
Marasini, L., Fiore, M., Arcidiacono, C., & Maghnie, M. (2026) · Medico e Bambino - Pagine Elettroniche · doi:10.53126/mebxxixo223
Anatomical Features versus ResNet-18 for Hypertrophic Cardiomyopathy Classification from Cardiac MRIPreprint
Mullan, A., Raffal, S., & Jannabhatla, P. (2026) · SSRN Electronic Journal · doi:10.2139/ssrn.7565398
Cardiomyopathies in Pregnancy
Behnia, F., Clifford, C. C., Jain, S., Omere, C. I., Collins, A., & Pacheco, L. D. (2026) · Clinical Obstetrics & Gynecology · doi:10.1097/grf.0000000000001058
Cost-effectiveness of aficamten for obstructive hypertrophic cardiomyopathy: a model-based analysis from the perspective of the Chinese healthcare system
Zhai, F., Li, H., Jiang, C., Mao, J., Chen, J., & You, C. (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1938259
Beyond the sarcomere: copper chelation in hypertrophic cardiomyopathy
OWENS, A. T. (2026) · European Heart Journal · doi:10.1093/eurheartj/ehag720
Impact of sex and age on long-term prognosis in hypertrophic cardiomyopathy: A multicenter retrospective cohort study
Ma, H., Xu, F., Liu, L., Luo, R., Liu, M., Liu, T., & Li, X. (2026) · Heart & Lung · doi:10.1016/j.hrtlng.2026.102965
Associations of the single nucleotide polymorphism rs2228145 of the IL6R gene with features of the clinical course of hypertrophic cardiomyopathy
Bezhanishvili, T. G., Semernin, Е. N., Davydova, V. G., Andreeva, S. E., Streltsova, A. A., Полякова, А. А., Kostareva, A. A., & Gudkova, A. Y. (2026) · The Scientific Notes of the Pavlov University · doi:10.24884/1607-4181-2026-33-2-40-48
Trends in Preventing Sudden Cardiac Death in Hypertrophic Cardiomyopathy
Ramos, N., Reyes, X., Gimeno, J. R., & Molina, M. S. (2026) · Cardiogenetics · doi:10.3390/cardiogenetics16040022
Artificial Intelligence-Enhanced Electrocardiography for the Detection of Hypertrophic Cardiomyopathy in Athletes: A Systematic Review of Diagnostic Accuracy and External Validity
Quirino, L. D. M., Duarte, K. X., Pereira, S. G. P. J., Leff, G. D., Rafael, B. C. C., Pinto, M. B. A., Lopes, R., Simões, C. S., Soares, J. W. D. A., & Kieling, G. L. (2026) · Cureus · doi:10.7759/cureus.117692
Body Mass Index, Valsartan, and Myocardial Remodeling in Early‐Stage Hypertrophic Cardiomyopathy: A Secondary Analysis of the Randomized VANISH Trial
Ostrominski, J. W., Claggett, B. L., Jerosch‐Herold, M., Raja, A. A., Day, S. M., Russell, M. W. W., Zahka, K. G., Pereira, A. C., Colan, S. D., Murphy, A. M., et al. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.126.050131
Self-citation
The effect of different exercise modalities on the maximal left ventricular outflow tract gradient in patients with obstructive hypertrophic cardiomyopathy
Möbius-Winkler, M. N., Hagendorff, A., Stöbe, S., Gaier, M., Kögel, A., Antoniadis, M., Laufs, U., Metze, M., Lenk, K., & Kandels, J. (2026) · Echo Research and Practice · doi:10.1186/s44156-026-00141-3
Interventricular septal thickness for cardiomyopathic phenotype enrichment in patients with established left ventricular hypertrophy
Wang, W.-T., Chen, H., & Yu, W.-C. (2026) · The International Journal of Cardiovascular Imaging · doi:10.1007/s10554-026-03839-x
Fibro-Inflammatory Signaling, Fibrosis, and Microvascular Ischemia as Convergent Translational Substrates of Sudden Cardiac Death in Hypertrophic Cardiomyopathy: A Systematic Review
Menezes, A. D. S., Wastowski, I. J., & Carneiro, L. C. (2026) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-026-10853-w
Use Of a Selective Cardiac Myosin Atpase Inhibitor in a Patient with Hypertrophic Cardiomyopathy with Critical Left Ventricular Outflow Tract Obstruction and Pulmonary Hypertension
Krylova, N. S., Потешкина, Н. Г., Анатольевна, К. Е., Svanadze, A. M., Spesivtseva, A. P., & Maslova, M. Y. (2026) · The Russian Archives of Internal Medicine · doi:10.33396/2226-6704-2026-16-5-392-400
Prevalence of Guideline-Recommended Genetic Testing in Patients at Risk for Heritable Thoracic Aortic Disease
Robledo, A., O’Leary, S., Pedrosa, D. D. T., Peñalver, J., & Sancassani, R. B. (2026) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2026.10.012
The Evolving Landscape of Hypertrophic Cardiomyopathy Treatment: Are Guidelines Keeping Pace?
Shusterman, V., Salamatbad, G., Weintraub, S. F., & Wharton, R. H. (2026) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000002245
The restore-adapt-abandon framework: supporting safe and meaningful living after ventricular assist device implantation
Bechthold, A. C., McIlvennan, C. K., Wells, R. D., Saylor, M. A., Moser, D. K., Matlock, D. D., & Dionne-Odom, J. N. (2026) · Heart & Lung · doi:10.1016/j.hrtlng.2026.102974
First Colombian Experience with Mavacamten in Obstructive Hypertrophic Cardiomyopathy: A Brief Imaging Report
Vásquez, J. F., Idrovo-Turbay, A., Reyes, R., David-Pardo, D. G., & Acuña-Olmos, J. (2026) · ARQUIVOS BRASILEIROS DE CARDIOLOGIA - IMAGEM CARDIOVASCULAR · doi:10.36660/abcimg.20260061
The cardiac myosin binding protein-C–myosin S2 interaction: modulation of cardiac contractility and its role in hypertrophic cardiomyopathy
Rzewnicki, S., McNamara, J. W., Seffrood, M. M., Churko, J. M., Tong, C. W.-C., Colson, B. A., & Sadayappan, S. (2026) · Journal of Molecular and Cellular Cardiology Plus · doi:10.1016/j.jmccpl.2026.100877
Left Ventricular Wall Thickness in Hypertrophic Cardiomyopathy and Cardiac Amyloidosis: A Multimodality Imaging Comparison
Bashir, Z. S., Bukhari, S. A., Yang, M., Jamil, H., Abdallah, M. B., Odigie‐Okon, E., & Khalife, W. I. (2026) · Journal of Clinical Medicine · doi:10.3390/jcm15208083
From Monogenic Variants to Polygenic Risk Scores in Inherited Cardiomyopathies: Clinical Utility, Ancestry Gaps, and Future Implementation in Arab Populations
Al‐Saud, S. A. (2026) · Genes · doi:10.3390/genes17101312
Association of Left Ventricular Outflow Tract Obstruction with Left Atrial Remodeling and Dysfunction in Hypertrophic Cardiomyopathy: A Three‐Dimensional Echocardiography and Left Atrial Strain Study
Lin, W., Zhong, R., Que, Q., Lin, W., 朱瑞娥, & Cai, F. (2026) · Echocardiography · doi:10.1111/echo.70653
Research trends and hotspot analysis of sudden cardiac death in hypertrophic cardiomyopathy
Chen, Z., Ai, F., Li, J., & Li, Y. (2026) · Medicine · doi:10.1097/md.0000000000051272
Efficacy and Safety of Pharmacologic Therapies in Nonobstructive Hypertrophic Cardiomyopathy: A Systematic Review
Patel, S., Gandhi, A. R., Pabani, A., Shah, R., Shah, P. V., Martinez, M. W., & Bavishi, A. A. (2026) · Journal of the American Heart Association · doi:10.1161/jaha.126.051256
Self-citation
Longitudinal Cardiac MRI Reveals Phenotypic Evolution of MYBPC3 -Associated Hypertrophic Cardiomyopathy Following Acute Myocarditis
Ma, X., Li, S., Chen, X., & Zhou, X. (2026) · Korean Journal of Radiology · doi:10.3348/kjr.2026.1079
Diastolic Dysfunction Predicts Cardiorespiratory Fitness and Clinical Outcomes in Hypertrophic CardiomyopathyPreprint
Pepin, M. E., O’Sullivan, J. W., Gjermeni, D., Santana, E. J., Mosher, B. P., Malunjkar, S., Tso, J., Ashley, E. A., Lewis, E. F., Christle, J. W., et al. (2026) · medRxiv · doi:10.64898/2026.10.23.26366319
Functional Recovery After Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy—When Measured Success Does Not Equal Complete Recovery
Burazor, I., & Ilić, I. (2026) · Diagnostics · doi:10.3390/diagnostics16213478
Clinical effectiveness of mavacamten on cardiac function and disease-related indicators in patients with obstructive hypertrophic cardiomyopathy
Shi, Y., Huang, J.-J., Liu, H.-Z., Xu, Y., & 原芳 (2026) · Frontiers in Pharmacology · doi:10.3389/fphar.2026.1861248
Takotsubo Cardiomyopathy with Left Ventricular Outflow Tract Obstruction Managed with Veno‑Venous Extracorporeal Membrane Oxygenation and Alcohol Septal Ablation
Jennings, C., Mihama, T., Ryan, W. H., Augoustides, J. G., Sacks, S., Cardi, A. I., Shapeton, A. D., Ortoleva, J. P., Morris, B. N., & Fernando, R. J. (2026) · Journal of Cardiothoracic and Vascular Anesthesia · doi:10.1053/j.jvca.2026.10.037
Predictive Value of P-Wave Dispersion Combined with Left Atrial Reservoir Strain for Incident Atrial Fibrillation in Patients with Hypertrophic Cardiomyopathy: A Retrospective Cohort Study
Yu, L., Zhang, Y., Sun, D., Hou, A., & Xia, F. (2026) · International Journal of General Medicine · doi:10.2147/ijgm.s646378
Beyond the ventricle: the atrial contribution to feline hypertrophic cardiomyopathy and implications for diagnosis, prognosis, and emerging therapy
Kongchatree, S., & Rattanasrisomporn, J. (2026) · Frontiers in Veterinary Science · doi:10.3389/fvets.2026.1979805
Percutaneous Intramyocardial Septal Radiofrequency Ablation (Liwen Procedure) for Hypertrophic Cardiomyopathy: A Decade of Evolution, Clinical Experience and Future Perspectives
Liu, L., Li, J., Dang, S., Hsi, D. H., & Ta, S. (2026) · Advanced ultrasound in diagnosis and therapy · doi:10.26599/audt.2026.260038
Metabolic Modulation in Hypertrophic Cardiomyopathy: A Systematic Review of Clinical and Observational Evidence
Chew, S. W., Yi, J. C. Z., Rong, S. L. J., Wei, N. Y. Z., Mohamad, M. S. F., Lang, C. C., & Choy, A. M. (2026) · European Cardiology Review · doi:10.15420/ecr.2025.94
Cat eye syndrome chromosome region, candidate 1 is a novel prognostic biomarker in hypertrophic cardiomyopathy
Zhang, Y., Wan, F., Li, C., Wang, B., Zhang, M., Lu, M., Kang, L., Liu, L., Wang, J., & Song, L. (2026) · Molecular Biomedicine · doi:10.1186/s43556-026-00648-5
CMR Characterization of Hypertrophic Heart Diseases
Quinn, S., & Allen, B. D. (2026) · Journal of Thoracic Imaging · doi:10.1097/rti.0000000000000915
Atrial remodelling defines the heart failure phenotype in hypertrophic cardiomyopathy
Melot, A., Wazzan, A. A., Saadi, M. P., Ortega, S. G. D. A., Bézard, M., & Donal, E. (2026) · Open Heart · doi:10.1136/openhrt-2026-004396
Prognostic value of native T1 mapping and extracellular volume fraction in hypertrophic cardiomyopathy: A systematic review and meta-analysis
Wang, Q., Liu, W., Shi, J., Li, W., Lin, J., Wang, Z., & Gao, Y. (2026) · European Journal of Radiology Open · doi:10.1016/j.ejro.2026.100822
Left ventricular apical aneurysms in hypertrophic cardiomyopathy: Characteristics and adverse events. A comparative study with patients without aneurysm
Giannoglou, D., Zegkos, T., Rouskas, P., Karamitsos, T. D., Papanastasiou, C. A., Katranas, S. A., Gossios, T. D., Ziakas, A., Fragkakis, N., Parcharidou, D. G., et al. (2026) · Hellenic Journal of Cardiology · doi:10.1016/j.hjc.2026.10.007
Left Ventricular Global Longitudinal Strain Does Not Improve Identification of Nonsustained Ventricular Tachycardia in Patients with Hypertrophic Cardiomyopathy
Aydın, M. Z., Teber, M. K., & Arın, C. B. (2026) · Medicina · doi:10.3390/medicina62112137
Hypertrophic Cardiomyopathy With Superimposed Pre‐Eclampsia in a Grand Multiparous Woman
Boahene, P. Y., Ampofo, B. K., Gyabaah, S., Naab, R. T., Opare-Addo, K. A., Akowuah, E., Appiah, L. T., & Kokuro, C. (2026) · Clinical Case Reports · doi:10.1002/ccr3.73856
Post-TAVI Hypotension as a Diagnostic and Therapeutic Challenge: A Case Report of Delayed-Onset Suicide Left Ventricle
Pepe, M., Barnaba, I., Caretto, P., Mastrangelo, A., Moretti, M., Giordano, S. A., Tritto, R., & Ciccone, M. M. (2026) · Journal of Cardiovascular Development and Disease · doi:10.3390/jcdd13110558

Authors: Ommen, S. R., Ho, C. Y., Asif, I. M., Balaji, S., Burke, M. A., Day, S. M., Dearani, J. A., Epps, K. C., Evanovich, L., Ferrari, V. A., Joglar, J. A., Khan, S. S., Kim, J. J., Kittleson, M. M., Krittanawong, C., Martinez, M. W., Mital, S., Naidu, S. S., Saberi, S., Semsarian, C., Times, S., & Waldman, C. B.
Affiliations: American Medical Society for Sports Medicine (US)
HRS representative.
Lay stakeholder representative.
AHA/ACC Joint Committee on Clinical Practice Guidelines liaison.
American Hospital Association (US)
PACES representative.
Joint ACC/AHA staff representative.
ORCID: Ommen, Steve R.
Ho, Carolyn Y.
Asif, Irfan M.
Balaji, Seshadri
Burke, Michael A.
Day, Sharlene M.
Dearani, Joseph A.
Ferrari, Victor A.
Joglar, José A.
Khan, Sadiya S.
Kim, Jeffrey J.
Kittleson, Michelle M.
Krittanawong, Chayakrit
Martinez, Matthew W.
Mital, Seema
Naidu, Srihari S.
Saberi, Sara
Semsarian, Christopher
Venue: Circulation
Publisher: Ovid Technologies (Wolters Kluwer Health)
Published: 2024-06-04
Volume: 149
Issue: 23
Pages: e1239-e1311
ISSN: 0009-7322 (ISSN-L)
1524-4539
DOI: 10.1161/cir.0000000000001250
OpenAlex: W4396750647
Cited by: 807
References: 514
Citations by year: 2026: 353 · 2025: 372 · 2024: 82
FWCI: 226.55
Type: journal article
Language: en
Update notices: correction (2024-08-19)
Open access: closed
Locations: Circulation (publishedVersion)
PubMed (publishedVersion)
Topics: Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiomyopathy and Myosin Studies
Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiovascular Effects of Exercise
Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
Keywords: hypertrophic cardiomyopathy, disease management, inherited heart disease, diagnosis, treatment guidelines, American Heart Association, American College of Cardiology, American Society of Echocardiography
MeSH terms: American Heart Association, Cardiology, Cardiomyopathy, Hypertrophic, Humans, United States, Disease Management

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy: A Report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks